Psoriatic Arthritis

Apremilast (Otezla) is the first oral therapy FDA approved to improve signs and symptoms, including physical functioning for patients with this condition.

A recent study compared the annual cost per treated patient for a health plan for patients taking etanercept, adalimumab, or infliximab.

Humira, Abbott's biggest seller, was recently approved by the FDA to treat ulcerative colitis.

A new study finds that patients with autoimmune diseases being treated with immunosuppressive drugs are not at an increased risk of developing shingles.